EDGAR Filing Documents for 0001193125-08-067071

Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:

SEC Accession No. 0001193125-08-067071

Filing Date

2008-03-27

Accepted

2008-03-27 15:24:55

Documents

Period of Report

2007-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-KSB	d10ksb.htm	10KSB	536154
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	8210
3	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	dex312.htm	EX-31.2	8136
4	CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002	dex321.htm	EX-32.1	3530
5	CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002	dex322.htm	EX-32.2	3508
	Complete submission text file	0001193125-08-067071.txt		561071

Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705

Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700

Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)